DOST: Study on lagundi as COVID-19 supplemental treatment shows positive results | Inquirer News
Close  

DOST: Study on lagundi as COVID-19 supplemental treatment shows positive results

/ 07:05 PM October 05, 2021

MANILA, Philippines — The country’s study on herbal medicine lagundi as a supplementary treatment for COVID-19 patients showed “positive” results, the Department of Science and Technology (DOST) said Tuesday.

Jaime Montoya, Executive Director of the DOST-Philippine Council for Health Research and Development, said that the study was completed in the middle of September.

ADVERTISEMENT

“For lagundi, tapos na ang study (the study has been finished). We are looking at whether it can help alleviate or prevent progression of mild disease to moderate or severe cases to allow early resolution or improvement of symptoms,” he told reporters in an online interview.

“The results are being reviewed by our experts. What I can say is it is positive but I cannot give the specifics because it is being peer-reviewed,” he said.

FEATURED STORIES

In June, the DOST also said that lagundi can help mild COVID-19 patients get rid of their symptoms faster and speed up the return of their sense of smell, according to the preliminary findings of its study.

Meanwhile, Montoya said that the in-vitro study for the antiviral properties of the virgin coconut oil (VCO) for COVID-19 patients was already finished. He noted that the community-based study in Sta. Rosa, Laguna was also finished and published in the Journal of Functional Foods.

“There is still an ongoing clinical trial ng VCO na community-based kasi in-expand nila yung population ng Sta. Rosa to include other localities like Valenzuela to include the number of patients. Still looking at mild cases of COVID-19,” he said.

The VCO study for moderate to hospitalized cases of COVID-19 at the Philippine General Hospital in Manila has likewise been finished. Montoya said data from the study is already being analyzed.

The trials for another herbal plant tawa-tawa is still ongoing.

“We hope the study will be finished by the end of this month at least the recruitment of volunteers and hopefully the results will be out by November,” said Montoya.

RELATED STORIES

ADVERTISEMENT

Doctor develops VCO-lagundi spray for ‘symptomatic relief’ of COVID patients

DOST study shows lagundi helps rid patients of mild COVID-19 symptoms

je

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: coronavirus Philippines, COVID-19, DOST, lagundi, tawa-tawa, Virgin Coconut Oil
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.